Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3516-3525

  Materniak, Magdalena ^a   Hechler, Torsten ^b,c   Löchelt, Martin ^b   Kuźmak, Jacek ^a  

^a NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Wilex Biotechnology GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS ANTIBODY; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BOVINE FOAMY VIRUS; CALF (BOVINE); CONTROLLED STUDY; EXPERIMENTAL INFECTION; FETUS; INOCULATION; LEUKOCYTE; LIVER; LUNG; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS INFECTION; SALIVARY GLAND; SHEEP; SPLEEN; SPUMA VIRUS; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DISEASE MODELS, ANIMAL; DNA, VIRAL; LEUKOCYTES; LIVER; LUNG; MOLECULAR SEQUENCE DATA; SALIVARY GLANDS; SEQUENCE ANALYSIS, DNA; SHEEP; SHEEP DISEASES; SPLEEN; SPUMAVIRUS;

EID: 84874673821     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02447-12     Document Type: Article

References (63)

1. Meiering CD, Linial ML. 2001. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14:165-176.
2. Saïb A. 2003. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 277:197-211.
3. Switzer WM, Salemi M, Shanmugam V, Gao F, Cong ME, Kuiken C, Bhullar V, Beer BE, Vallet D, Gautier-Hion A, Tooze Z, Villinger F, Holmes EC, Heneine W. 2005. Ancient co-speciation of simian foamy viruses and primates. Nature 434:376-380.
4. Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D. 1997. Simian foamy virus isolated from an accidentally infected human individual. J. Virol. 71:4821-4824.
5. Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, Prosser AT, Torimiro JN, Wright A, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Heneine W. 2004. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363:932-937.
6. Jones-Engel L, Engel GA, Schillaci MA, Rompis A, Putra A, Suaryana KG, Fuentes A, Beer B, Hicks S, White R, Wilson B, Allan JS. 2005. Primate-to-human retroviral transmission in Asia. Emerg. Infect. Dis. 11: 1028-1035.
7. Calattini S, Betsem EB, Froment A, Mauclere P, Tortevoye P, Schmitt C, Njouom R, Saïb A, Gessain A. 2007. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg. Infect. Dis. 13:1314-1320.
8. Betsem E, Rua R, Tortevoye P, Froment A, Gessain A. 2011 Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog. 7:e1002306. doi:10.1371/journal.ppat .1002306.
9. Mouinga-Ondémé A, Caron M, Nkoghé D, Telfer P, Marx P, Saïb A, Leroy E, Gonzalez J-P, Gessain A, Kazanji M. 2012. Genetic diversity and evolution cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa. J. Virol. 86:1255-1260.
10. Callahan ME, Switzer WM, Matthews AL, Roberts BD, Heneine W, Folks TM, Sandstrom PA. 1999. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J. Virol. 73:9619-9624.
11. Rua R, Betsem E, Calattini S, Saib A, Gessain A. 2012. Genetic characterization of simian foamy viruses infecting humans. J. Virol. 86:13350-13359.
12. Löchelt M, Romen F, Bastone P, Muckenfuss H, Kirchner N, Kim YB, Truyen U, Rösler U, Battenberg M, Saib A, Flory E, Cichutek K, Münk C. 2005. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U. S. A. 102:7982-7987.
13. Neil S, Bieniasz P. 2009. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29:569-580.
14. Perković M, Schmidt S, Marino D, Russell RA, Stauch B, Hofmann H, Kopietz F, Kloke BP, Zielonka J, Ströver H, Hermle J, Lindemann D, Pathak VK, Schneider G, Löchelt M, Cichutek K, Münk C. 2009. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein Bet. J. Biol. Chem. 284:5819-5826.
15. Zielonka J, Marino D, Hofmann H, Yuhki N, Löchelt M, Münk C. 2010. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J. Virol. 84:7312-7324.
16. Santillana-Hayat M, Rozain F, Bittoun P, Chopin-Robert C, Lasneret J, Peries J, Canivet M. 1993. Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res. Virol. 144:389-396.
17. Murray SM, Picker LJ, Axthelm MK, Linial ML. 2006. Expanded tissue targets for foamy virus replication with simian immunodeficiency virusinduced immunosuppression. J. Virol. 80:663-670.
18. Bastone P, Truyen U, Löchelt M. 2003. Potential of zoonotic transmission of non-primate foamy viruses to humans. J. Vet. Med. B Infect. Dis. Vet. Public Health 50:417-423.
19. Switzer WM, Bhullar V, Shanmugam V, Cong ME, Parekh B, Lerche NW, Yee JL, Ely JJ, Boneva R, Chapman LE, Folks TM, Heneine W. 2004. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 78:2780-2789.
20. Rethwilm A. 2007. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors. Curr. Gene Ther. 7:261-271.
21. Romen F, Backes P, Materniak M, Sting R, Vahlenkamp TW, Riebe R, Pawlita M, Kuzmak J, Löchelt M. 2007. Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology 364:123-131.
22. Materniak M, Sieradzki Z, Kuźmak J. 2010. Detection of bovine foamy virus in milk and saliva of BFV seropositive cattle. Bull. Vet. Inst. Pulawy 54:461-465.
23. Lindemann D, Rethwilm A. 2011. Foamy virus biology and its application for vector development. Viruses 3:561-585.
24. Woode GN. 1972. Isolation of bovine syncytial virus in Britain. Vet. Rec. 91:363.
25. Clarke JK, McFerran JB, Nelson RT. 1973. The isolation of a strain of bovine syncytial virus in Northern Ireland. Res. Vet. Sci. 14:117-119.
26. Greig AS. 1979. A syncytium regression test to detect antibodies to bovine syncytial virus. Can. J. Comp. Med. 43:112-114.
27. Jacobs RM, Pollari FL, McNab WB, Jefferson B. 1995. A serological survey of bovine syncytial virus in Ontario: associations with bovine leukemia and immunodeficiency-like viruses, production records, and management practices. Can. J. Vet. Res. 59:271-278.
28. Materniak M, Bicka L, Kuźmak J. 2006. Isolation and partial characterization of bovine foamy virus from Polish cattle. Pol. J. Vet. Sci. 9:207-211.
29. Malmquist WA, Maaten MJ van der, Boothe AD. 1969. Isolation, immunodiffusion, immunofluorescence and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle. Cancer Res. 29:188-200.
30. Gould EA, Allan GM, Logan EF, McFerran JB. 1978. Detection of antibody to bovine syncytial virus and respiratory syncytial virus in bovine fetal serum. J. Clin. Microbiol. 8:233-237. 31. Flanagan M. 1992. Isolation of a spumavirus from a sheep. Aust. Vet. J. 69:112-113.
31. Flanagan M. 1992. Isolation of a spumavirus from a sheep. Aust. Vet. J. 69:112-113.
32. Jacobs RM, Smith HE, Whetstone CA, Suarez DL, Jefferson B, Valli VE. 1994. Haematological and lymphocyte subset analyses in sheep inoculated with bovine immunodeficiency-like virus. Vet. Res. Commun. 18:471-482.
33. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A. 2012. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647-1649.
34. Johnson RH, Oginnusi AA, Ladds PW. 1983. Isolations and serology of bovine spumavirus. Aust. Vet. J. 60:147.
35. Renshaw RW, Gonda MA, Casey JW. 1991. Structure and transcriptional status of bovine syncytial virus in cytopathic infections. Gene 105:179-184.
36. Münk C, Hechler T, Chareza S, Löchelt M. 2010. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins. Vet. Immunol. Immunopathol. 134:14-24.
37. Winkler IG, Flügel RM, Löchelt M, Flower RL. 1998. Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats. Virology 247:144-151.
38. Zemba M, Alke A, Bodem J, Winkler IG, Flower RL, Pfrepper K, Delius H, Flügel RM, Löchelt M. 2000. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences. Virology 266:150-156.
39. Lindemann D, Goepfert PA. 2003. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 277:111-129.
40. Agnarsdóttir G, Thorsteinsdóttir H, Oskarsson T, Matthíasdóttir S, Haflidadóttir BS, Andrésson OS, Andrésdóttir V. 2000. The long terminal repeat is a determinant of cell tropism of maedi-visna virus. J. Gen. Virol. 81:1901-1905.
41. Zhao X, Jimenez C, Sentsui H, Buehring GC. 2007. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences. Virus Res. 124:113-124.
42. Renshaw RW, Casey JW. 1994. Analysis of the 5' long terminal repeat of bovine syncytial virus. Gene 141:221-224.
43. Hechler T, Materniak M, Kehl T, Kuźmak J, Löchelt M. 2012. Complete genome sequences of two novel European clade bovine foamy viruses from Germany and Poland. J. Virol. 86:10905-10906.
44. Saïb A, Neves M, Giron ML, Guillemin MC, Valla J, Peries J, Canivet M. 1997. Long-term persistent infection of domestic rabbits by the human foamy virus. Virology 228:263-268.
45. Hooks JJ, Detrick-Hooks B. 1979. Simian foamy virus-induced immunosuppression in rabbits. J. Gen. Virol. 44:383-390.
46. Brown P, Moreau-Dubois MC, Gajdusek DC. 1982. Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retrovirus latency. Arch. Virol. 71:229-234.
47. Falcone V, Schweizer M, Neumann-Haefelin D. 2003. Replication of primate foamy viruses in natural and experimental hosts. Curr. Top. Microbiol. Immunol. 277:161-180.
48. Hooks JJ, Gibbs CJ, Jr. 1975. The foamy viruses. Bacteriol. Rev. 39:169-185.
49. Falcone V, Leupold J, Clotten J, Urbanyi E, Herchenröder O, Spatz W, Volk B, Böhm N, Toniolo A, Neumann-Haefelin D, Schweizer M. 1999. Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257:7-14.
50. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I. 1991. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253:555-557.
51. Eschbaumer M, Wäckerlin R, Rudolf M, Keller M, König P, Zemke J, Hoffmann B, Beer M. 2010. Infectious blood or culture-grown virus: a comparison of bluetongue virus challenge models. Vet. Microbiol. 146: 150-154.
52. Hahn H, Baunach G, Brautigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure MO, Rethwilm A. 1994. Reactivity of primate sera to foamy virus Gag and Bet proteins. J. Gen. Virol. 75:2635-2644.
53. Bleiholder A, Mühle M, Hechler T, Bevins S, vande Woude S, Denner J, Löchelt M. 2011. Pattern of seroreactivity against feline foamy virus proteins in domestic cats from Germany. Vet. Immunol. Immunopathol. 143:292-300.
54. Brodie SJ, Pearson LD, Zink MC, Bickle HM, Anderson BC, Marcom KA, DeMartini JC. 1995. Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues. Am. J. Pathol. 146:250-263.
55. + lymphocytes in the lung of individuals infected with HIV accompanied by increased virus production in patients with secondary infections. Clin. Exp. Immunol. 102:231-237.
56. Carrozza ML, Mazzei M, Bandecchi P, Arispici M, Tolari F. 2003. In situ PCR-associated immunohistochemistry identifies cell types harbouring the Maedi-Visna virus genome in tissue sections of sheep infected naturally. J. Virol. Methods 107:121-127.
57. McNeilly TN, Baker A, Brown JK, Collie D, Maclachlan G, Rhind SM, Harkiss GD. 2008. Role of alveolar macrophages in respiratory transmission of Visna/Maedi virus. J. Virol. 82:1526-1536.
58. von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M. 1996. Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 221:240-244.
59. German AC, Harbour DA, Helps CR, Gruffydd-Jones TJ. 2008. Is feline foamy virus really apathogenic? Vet. Immunol. Immunopathol. 123:114-118.
60. Russell RA, Wiegand HL, Moore MD, Schäfer A, McClure MO, Cullen BR. 2005. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 79: 8724-8731.
61. McClure MO, Bieniasz PD, Schulz TF, Chrystie IL, Simpson G, Aguzzi A, Hoad JG, Cunningham A, Kirkwood J, Weiss RA. 1994. Isolation of a new foamy retrovirus from orangutans. J. Virol. 68:7124-7130.
62. Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, McClure MO. 1995. A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology 207:217-228.
63. Schweizer M, Neumann-Haefelin D. 1995. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577-582.